首页> 外文期刊>Spectrochimica acta, Part A. Molecular and biomolecular spectroscopy >Novel absorptivity centering method utilizing normalized and factorized spectra for analysis of mixtures with overlapping spectra in different matrices using built-in spectrophotometer software
【24h】

Novel absorptivity centering method utilizing normalized and factorized spectra for analysis of mixtures with overlapping spectra in different matrices using built-in spectrophotometer software

机译:利用归一化和分解光谱分析不同矩阵中的混合物分析的归一化和分解光谱的新型吸收性定心方法使用内置分光光度计软件

获取原文
获取原文并翻译 | 示例
           

摘要

A novel, simple, rapid, accurate, and economical spectrophotometric method, namely absorptivity centering (a-Centering) has been developed and validated for the simultaneous determination of mixtures with partially and completely overlapping spectra in different matrices using either normalized or factorized spectrum using builtin spectrophotometer software without a need of special purchased program. Mixture I (Mix I) composed of Simvastatin (SM) and Ezetimibe (EZ) is the one with partial overlapping spectra formulated as tablets, while mixture II (Mix II) formed by Chloramphenicol (CPL) and Prednisolone acetate (PA) is that with complete overlapping spectra formulated as eye drops. These procedures do not require any separation steps. Resolution of spectrally overlapping binary mixtures has been achieved getting recovered zero-order (D-0) spectrum of each drug, then absorbance was recorded at their maxima 238, 233.5, 273 and 242.5 nm for SM, EZ, CPL and PA, respectively. Calibration graphs were established with good correlation coefficients. The method shows significant advantages as simplicity, minimal data manipulation besides maximum reproducibility and robustness. Moreover, it was validated according to ICH guidelines. Selectivity was tested using laboratory-prepared mixtures. Accuracy, precision and repeatability were found to be within the acceptable limits. The proposed method is good enough to be applied to an assay of drugs in their combined formulations without any interference from excipients. The obtained results were statistically compared with those of the reported and official methods by applying t-test and F-test at 95% confidence level concluding that there is no significant difference with regard to accuracy and precision. Generally, this method could be used successfully for the routine quality control testing. (C) 2018 Elsevier B.V. All rights reserved.
机译:已经开发了一种新颖的,简单,快速,准确,经济的分光光度法,即吸收率(以定心),并验证了使用内置的标准化或分解光谱在不同矩阵中同时确定具有部分和完全重叠光谱的混合物的混合物分光光度计软件无需特殊购买的程序。由辛伐他汀(SM)和Ezetimibe(EZ)组成的混合物I(混合物I)是配制作为片剂的部分重叠光谱的混合物,而通过氯霉素(CPL)和乙酸乙酸盐(PA)形成的混合物II(混合物II)是完整的重叠光谱配制为耳滴。这些程序不需要任何分离步骤。已经实现了分辨率的分辨率已经达到了每个药物的零阶(D-0)谱,然后在其最大值238,233.5,273和242.5nm中记录吸光度,分别用于SM,EZ,CPL和PA。以良好的相关系数建立校准图。该方法显示出显着的优点,作为简单性,最小的数据操作,除了最大再现性和鲁棒性之外。此外,根据ICH指南验证。使用实验室制备的混合物测试选择性。发现准确性,精度和可重复性在可接受的限度范围内。所提出的方法足以应用于其组合制剂中药物的测定,而不会从赋形剂的干扰干扰。通过在95%的置信水平上施加T-Test和F-Tesce,与报告的和官方方法的结果进行了统计学统计学比较,在95%的置信水平上得出结论,在准确性和精度方面没有显着差异。通常,该方法可以成功地用于常规质量控制测试。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号